Literature DB >> 21459667

Mercapturic acids as metabolites of alkylating substances in urine samples of German inhabitants.

Elisabeth Eckert1, Klaus Schmid, Barbara Schaller, Kerstin Hiddemann-Koca, Hans Drexler, Thomas Göen.   

Abstract

Hydroxyalkyl mercapturic acids (HAMA) are the main urinary metabolites of several alkylating substances that possess a carcinogenic potential, like acrolein, 1,3-butadiene, ethylene oxide, propylene oxide and glycidol. These alkylating substances are used extensively in industrial processes, but they do also occur environmentally, e.g. in tobacco smoke. The aim of this study was the determination of six HAMA, as biomarkers of exposure, in human urine of smokers and non-smokers. We applied a sensitive analytical method, using hydrophilic interaction liquid chromatography with tandem mass spectrometry (HILIC-MS/MS) for the determination of 2-hydroxyethyl mercapturic acid (HEMA, biomarker for ethylene oxide), 2-hydroxypropyl mercapturic acid (2-HPMA, biomarker for propylene oxide), 3-hydroxypropyl mercapturic acid (3-HPMA, biomarker for acrolein), 2,3-dihydroxypropyl mercapturic acid (DHPMA, biomarker for glycidol) as well as 3,4-dihydroxybutyl mercapturic acid and 3-monohydroxybutenyl mercapturic acids (DHBMA and MHBMA, biomarkers for 1,3-butadiene). Background concentrations of four HAMA were detected in each urine sample we analyzed. The mercapturic acids HEMA and MHBMA were detected in 55% and 10% of the samples, respectively. In the urine of non-smokers (n = 54) we observed median levels of 206, 1.6, 12.1, 146, 159, and <5.0 μg/g creatinine for DHPMA, HEMA, 2-HPMA, 3-HPMA, DHBMA and MHBMA, respectively. Among smokers (n = 40) median levels of DHPMA, HEMA, 2-HPMA, 3-HPMA, DHBMA and MHBMA were determined to be 217, 4.9, 46.2, 884, 211 and <5.0 μg/g creatinine, respectively. The excretion rate of the biomarkers HEMA, 2-HPMA and 3-HPMA was distinctly higher in smokers than in non-smokers. Furthermore, our study revealed a comparatively high background level of DHPMA in urine of smokers and non-smokers whose origin is still unknown. The presented data may contribute to the evaluation of reference values for urinary HAMA levels in the general population.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459667     DOI: 10.1016/j.ijheh.2011.03.001

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  16 in total

1.  Intake of toxic and carcinogenic volatile organic compounds from secondhand smoke in motor vehicles.

Authors:  Gideon St Helen; Peyton Jacob; Margaret Peng; Delia A Dempsey; S Katharine Hammond; Neal L Benowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-14       Impact factor: 4.254

2.  Effect of cigarette smoking on urinary 2-hydroxypropylmercapturic acid, a metabolite of propylene oxide.

Authors:  Adam T Zarth; Steven G Carmella; Chap T Le; Stephen S Hecht
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-02-14       Impact factor: 3.205

3.  Hemoglobin adducts as an important marker of chronic exposure to low concentration of 1, 3-butadiene.

Authors:  Reza Ahmadkhaniha; Faezeh Izadpanah; Noushin Rastkari
Journal:  J Environ Health Sci Eng       Date:  2021-08-09

4.  Application of biological monitoring for exposure assessment of 1.3 Butadiene.

Authors:  Reza Ahmadkhaniha; Mahboobeh Ghoochani; Noushin Rastkari
Journal:  J Environ Health Sci Eng       Date:  2020-09-28

5.  Exposure to 1,3-Butadiene in the U.S. Population: National Health and Nutrition Examination Survey 2011-2016.

Authors:  Alma Nieto; Luyu Zhang; Deepak Bhandari; Wanzhe Zhu; Benjamin C Blount; Víctor R De Jesús
Journal:  Biomarkers       Date:  2021-04-08       Impact factor: 2.663

6.  Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach.

Authors:  Evan O Gregg; Emmanuel Minet; Michael McEwan
Journal:  Biomarkers       Date:  2013-07-31       Impact factor: 2.658

7.  Exposome of attention deficit hyperactivity disorder in Taiwanese children: exploring risks of endocrine-disrupting chemicals.

Authors:  Alexander Waits; Chia-Huang Chang; Ching-Jung Yu; Jung-Chieh Du; Hsien-Chih Chiou; Jia-Woei Hou; Winnie Yang; Hsin-Chang Chen; Ying-Sheue Chen; Betau Hwang; Mei-Lien Chen
Journal:  J Expo Sci Environ Epidemiol       Date:  2021-07-15       Impact factor: 5.563

8.  Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquid.

Authors:  Anne Landmesser; Max Scherer; Gerhard Scherer; Mohamadi Sarkar; Jeffery S Edmiston; Reinhard Niessner; Nikola Pluym
Journal:  Arch Toxicol       Date:  2021-06-22       Impact factor: 5.153

9.  Exposure to tobacco smoke based on urinary cotinine levels among Israeli smoking and nonsmoking adults: a cross-sectional analysis of the first Israeli human biomonitoring study.

Authors:  Hagai Levine; Tamar Berman; Rebecca Goldsmith; Thomas Göen; Judith Spungen; Lena Novack; Yona Amitai; Tamy Shohat; Itamar Grotto
Journal:  BMC Public Health       Date:  2013-12-30       Impact factor: 3.295

10.  Acrolein exposure is associated with increased cardiovascular disease risk.

Authors:  Natasha DeJarnett; Daniel J Conklin; Daniel W Riggs; John A Myers; Timothy E O'Toole; Ihab Hamzeh; Stephen Wagner; Atul Chugh; Kenneth S Ramos; Sanjay Srivastava; Deirdre Higdon; David J Tollerud; Andrew DeFilippis; Carrie Becher; Brad Wyatt; James McCracken; Wes Abplanalp; Shesh N Rai; Tiffany Ciszewski; Zhengzhi Xie; Ray Yeager; Sumanth D Prabhu; Aruni Bhatnagar
Journal:  J Am Heart Assoc       Date:  2014-08-06       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.